4/A: Ormat Director Corrects Stock Appreciation Rights Filing
Form 4/A Amendment
Director David Granot filed an amendment to correct the reporting of Stock Appreciation Rights exercise and subsequent share sales.
Summary
- Director David Granot exercised 1,315 Stock Appreciation Rights (SARs) at an exercise price of $67.54.
- The exercise resulted in a net issuance of 112 shares after accounting for the difference between the market value ($73.84) and the exercise price.
- The reporting person subsequently sold a total of 838 shares in the open market at prices ranging from $72.99 to $73.011.
- This filing serves as an amendment to a previously filed Form 4 to accurately reflect the SAR exercise and tax-related dispositions.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative update intended to correct a clerical error in a previous regulatory filing.
Positives
- The amendment provides transparency and corrects previous reporting errors regarding equity compensation.
- The director maintains a direct beneficial ownership of 2,825 shares following the transactions.
Negatives
- The initial filing on May 15, 2025, contained reporting inaccuracies regarding the nature of the SAR exercise and share dispositions.
Risks
- Regulatory scrutiny regarding the accuracy of Section 16 filings.
Future Outlook
No forward-looking guidance or strategic outlook provided in this administrative filing.
Industry Context
StockSavvy.ai notes that administrative amendments to insider filings are common and generally do not reflect changes in company fundamentals or strategic direction.
Comparison to Industry Standards
- The filing follows standard SEC disclosure requirements for executive and director equity transactions.
- The correction of reporting errors is consistent with standard corporate governance compliance practices.
Stakeholder Impact
- Minimal impact on shareholders as this is a routine correction of an insider transaction report.
Next Steps
- No further actions or milestones mentioned.
Key Dates
| Date | Description |
|---|---|
| 2021-11-04 | Grant date of the Stock Appreciation Rights. |
| 2025-05-13 | Date of the SAR exercise and subsequent open market sales. |
| 2025-05-15 | Date of the original, incorrect Form 4 filing. |
| 2025-05-21 | Date of the amended Form 4/A filing. |
| 2026-11-04 | Expiration date of the original SARs. |
Keywords
Ormat Technologies, ORA, Form 4, Insider Trading, Stock Appreciation Rights, Director Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.